GLP-1 injection technique — practical guide for Indian patients

Short answer

GLP-1 injections in India use prefilled pens injected subcutaneously into abdomen, thigh, or upper arm once weekly for most semaglutide products, with site rotation and new needles each time. Unopened pens refrigerate at 2–8°C; after first use many tolerate room temperature up to 30°C for several weeks. Licensed clinics offer technique demos. Schedule H sourcing only.

Which injection sites are recommended for GLP-1 pens?

Subcutaneous injection into abdomen at least five centimetres from the navel, front of thigh, or upper arm are standard sites for weekly GLP-1 pens. Rotate sites each week to reduce lipodystrophy and bruising. Avoid scar tissue, moles, and inflamed skin. Many Indian endocrine clinics demonstrate technique on first visit—request nurse training if self-injecting for the first time. Family caregivers can learn administration for elderly patients with tremor or vision limitations. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions. Document HbA1c, waist circumference, and weight trends for follow-up visits in metro and tier-2 Indian practice. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions.

What step-by-step technique reduces pain and waste?

Wash hands, attach a new sterile needle, prime the pen per insert instructions if required, select dose, pinch a skin fold gently, inject at ninety degrees for most needles, hold ten seconds, then dispose of needle in a sharps container. Never reuse needles—reuse blunts tips and raises infection risk. Do not massage the site vigorously. If blood appears, apply light pressure with clean gauze. Record date, site, and dose in a diary for physician review. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions.

How should pens be stored during Indian summers?

Unopened pens require refrigeration at 2–8°C—not freezer compartments. After first use, most semaglutide and tirzepatide pens tolerate room temperature up to 30°C for a defined period on the label—critical during heatwaves and power cuts. Use insulated pouches with ice gels for short travel; never freeze pens. Discard pens left in hot cars or exposed to direct sunlight for hours. Metro pharmacy cold-chain logs help verify handling before purchase. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions.

What sharps disposal rules apply in India?

Needles belong in puncture-proof containers—not household waste mixed with kitchen refuse. Many hospital pharmacies and municipal health programmes accept sealed sharps boxes. Apartment societies may lack formal collection—coordinate with local clinic disposal days. CDSCO-aligned patient education emphasises community safety. Kesho waste-disposal guide lists metro-specific options. Never recap needles by hand; use one-handed scoop technique or dispose immediately after injection. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions. Kesho provides drug-class education only—not prescribing advice. Verify CDSCO approval and Schedule H prescriptions at licensed Indian pharmacies before every refill.

How often are GLP-1 injections given in India?

Weekly injection covers most semaglutide and tirzepatide maintenance regimens after titration. Daily injection applies to liraglutide drug class members. Follow your prescription label exactly—dose escalation schedules reduce nausea. Missing a dose by a few days may require physician guidance on timing next injection. Do not double doses to compensate. Set recurring calendar reminders aligned with work travel or weekly fasting rituals if relevant to your household. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions. Kesho provides drug-class education only—not prescribing advice.

What injection errors should patients avoid?

Injecting intramuscularly by mistake, using expired pens, sharing pens between family members, or sourcing pens without valid Schedule H prescriptions are dangerous errors. Social-media videos sometimes show incorrect angles or reused needles. Verify technique with a healthcare professional—not influencers. If persistent injection-site nodules form, report to your doctor for site rotation review and possible allergy assessment. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions. Kesho provides drug-class education only—not prescribing advice. Verify CDSCO approval and Schedule H prescriptions at licensed Indian pharmacies before every refill.

Can domestic travel affect injection schedules?

Domestic flights and train journeys within India are compatible with weekly GLP-1 when pens stay cooled appropriately. Carry prescription copies and pharmacy invoices for security checks. Time-zone shifts within India rarely affect weekly schedules; international travel may need endocrinologist advice. Insulated cases prevent heat damage during summer AC failures in tier-2 lodging. See Kesho travel guide for festival and wedding season logistics. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions. Kesho provides drug-class education only—not prescribing advice.

When should you call your doctor about injections?

Persistent injection-site infections, severe rash, recurring hypoglycaemia if on combination diabetes therapy, or inability to administer due to disability warrant clinical contact. Training refresher visits help after switching pen brands during generic transitions. Report pen malfunction—dose counters stuck or leakage—before assuming full dose delivery. Emergency care is for allergic angioedema or breathing difficulty, not routine technique questions. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions. Kesho provides drug-class education only—not prescribing advice. Verify CDSCO approval and Schedule H prescriptions at licensed Indian pharmacies before every refill.

Where is the complete injection guide on Kesho?

Our full injection how-to guide includes diagrams, titration calendars, nurse-training checklist, and references aligned with RSSDI diabetes care pathways. This landing orients patients searching technique basics before first dose. Drug-class language applies across semaglutide, tirzepatide, and liraglutide pens with manufacturer-specific insert differences noted in the long guide. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised decisions. Kesho provides drug-class education only—not prescribing advice. Verify CDSCO approval and Schedule H prescriptions at licensed Indian pharmacies before every refill.

Quick questions

Is GLP-1 Injection How-To information on Kesho medical advice?
No. Kesho provides drug-class education only. Always consult a qualified endocrinologist, internal medicine specialist, or cardiologist for personalised treatment decisions.
Where is the full guide?
See our complete medically reviewed guide linked on this page for in-depth coverage with references and India-specific context.
What is the short answer on glp-1 injection how-to?
GLP-1 injections in India use prefilled pens injected subcutaneously into abdomen, thigh, or upper arm once weekly for most semaglutide products, with site rotation and new needles each time. Unopened pens refrigerate at 2–8°C; after first use many tolerate room temperature up to 30°C for several weeks. Licensed clinics offer technique demos. Schedule H sourcing only.

Related guides

GLP-1 access and cost in India illustrationIndia Access
5 min read

GLP-1 Pen Disposal in India: Safe Sharps and Waste Guide

Weekly GLP-1 injections generate sharps waste that most patients never think about until a used needle sits on the bathroom counter. Improper disposal risks sanitation workers, ragpickers, domestic help, and curious children across Indian cities where waste segregation remains inconsistent. Responsible sharps handling is an ethical duty of injectable therapy users—and a legal requirement under biomedical waste rules. Here is how to store, transport, and dispose of GLP-1 pens safely at home, at work, and while travelling.

Read guide →
Lifestyle and exercise on GLP-1 illustrationLifestyle
5 min read

Travelling on GLP-1 Therapy in India and Abroad

Domestic flights, monsoon train journeys, hill-station road trips, and NRI visits abroad all require planning when your medicine needs refrigeration and a fixed weekly injection day. Indian summer heat, unreliable train cooling, and airport security screening add layers beyond what Western travel guides assume. Whether you use injectable semaglutide or oral tablets, this guide covers packing, cold chain, time zones, and sharps disposal so treatment continues safely away from home.

Read guide →
Semaglutide patient guide for IndiaBasics
5 min read

Semaglutide in India: A Complete Patient Guide

Semaglutide has become one of the most discussed GLP-1 receptor agonists in India—for both blood sugar control and weight management. Whether you have heard about it from your diabetologist or read about generic versions entering the market, understanding the drug class (not just brand names) helps you make informed decisions with your doctor. This guide covers forms, dosing, costs, safety, and what CDSCO, RSSDI, and ICMR guidance mean for Indian patients considering or already using this molecule within the broader GLP-1 family. Generic competition, oral versus injectable choices, and out-of-pocket budgeting make 2026 a pivotal year for patients navigating this medicine responsibly under Schedule H rules.

Read guide →
Dr. Ananya Mehta

Medically reviewed

Dr. Ananya Mehta, MD, DM Endocrinology

Consultant Endocrinologist, India

This article has been reviewed by our medical advisory team, including endocrinologists, internal medicine specialists, and cardiologists, and is based on current scientific evidence and Indian clinical guidelines. Last reviewed: June 2026.

Last medically reviewed: Jun 15, 2026

Editorial policy · Medical advisory team